Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
von Wyl V, Yerly S, Böni J, Bürgisser P, Klimkait T, Battegay M, Furrer H, Telenti A, Hirschel B, Vernazza PL, Bernasconi E, Rickenbach M, Perrin L, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. von Wyl V, et al. Among authors: boni j. Arch Intern Med. 2007 Sep 10;167(16):1782-90. doi: 10.1001/archinte.167.16.1782. Arch Intern Med. 2007. PMID: 17846398
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
von Wyl V, Yerly S, Böni J, Bürgisser P, Klimkait T, Battegay M, Bernasconi E, Cavassini M, Furrer H, Hirschel B, Vernazza PL, Rickenbach M, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. von Wyl V, et al. Among authors: boni j. Clin Infect Dis. 2008 Apr 15;46(8):1299-309. doi: 10.1086/528863. Clin Infect Dis. 2008. PMID: 18444871 Free article.
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.
von Wyl V, Ehteshami M, Demeter LM, Bürgisser P, Nijhuis M, Symons J, Yerly S, Böni J, Klimkait T, Schuurman R, Ledergerber B, Götte M, Günthard HF; Swiss HIV Cohort Study. von Wyl V, et al. Among authors: boni j. Clin Infect Dis. 2010 Sep 1;51(5):620-8. doi: 10.1086/655764. Clin Infect Dis. 2010. PMID: 20666602 Free article.
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
Scherrer AU, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Garzoni C, Hirschel B, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; Swiss HIV Cohort Study (SHCS). Scherrer AU, et al. Among authors: boni j. J Acquir Immune Defic Syndr. 2011 May 1;57(1):24-31. doi: 10.1097/QAI.0b013e318211925e. J Acquir Immune Defic Syndr. 2011. PMID: 21283013
Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.
Scherrer AU, von Wyl V, Joos B, Klimkait T, Bürgisser P, Yerly S, Böni J, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. Scherrer AU, et al. Among authors: boni j. J Infect Dis. 2011 Mar 15;203(6):791-7. doi: 10.1093/infdis/jiq130. Epub 2011 Feb 1. J Infect Dis. 2011. PMID: 21285456 Free PMC article.
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.
Scherrer AU, Ledergerber B, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Rauch A, Hirschel B, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Held L, Günthard HF; Swiss HIV Cohort Study. Scherrer AU, et al. Among authors: boni j. Clin Infect Dis. 2011 Dec;53(11):1143-52. doi: 10.1093/cid/cir669. Epub 2011 Oct 13. Clin Infect Dis. 2011. PMID: 21998284 Free article.
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
von Wyl V, Yerly S, Böni J, Shah C, Cellerai C, Klimkait T, Battegay M, Bernasconi E, Cavassini M, Furrer H, Hirschel B, Vernazza PL, Ledergerber B, Günthard HF; Swiss HIV Cohort Study. von Wyl V, et al. Among authors: boni j. Clin Infect Dis. 2012 Jan 1;54(1):131-40. doi: 10.1093/cid/cir728. Epub 2011 Nov 4. Clin Infect Dis. 2012. PMID: 22057700 Free article.
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
Scherrer AU, Ledergerber B, von Wyl V, Böni J, Yerly S, Klimkait T, Cellerai C, Furrer H, Calmy A, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Günthard HF; Swiss HIV Cohort Study. Scherrer AU, et al. Among authors: boni j. PLoS One. 2012;7(6):e37983. doi: 10.1371/journal.pone.0037983. Epub 2012 Jun 18. PLoS One. 2012. PMID: 22719859 Free PMC article.
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
Scherrer AU, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Calmy A, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; Swiss HIV Cohort Study (SHCS). Scherrer AU, et al. Among authors: boni j. PLoS One. 2012;7(11):e50307. doi: 10.1371/journal.pone.0050307. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189194 Free PMC article.
494 results